FHAM
RMD icon

Folger Hill Asset Management’s ResMed RMD Stock Holding History

Folger Hill Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,304
Closed -$238K – 344
2017
Q1 		$238K Buy
+3,304
New +$228K 0.02% 292

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Folger Hill Asset Management's RMD Position: Q2 2017 in Review

Folger Hill Asset Management sold out of ResMed (RMD) in Q2 2017, closing a stake of 3,304 shares — an estimated $238K sold.

Folger Hill Asset Management first reported a position in RMD in Q1 2017 and held it in 1 quarter. The position peaked at $238K in Q1 2017. 339 funds tracked by Wall St. Rank hold RMD as of Q2 2017.

  • Folger Hill Asset Management reported no remaining ResMed position as of Q2 2017 after selling out during the quarter.
  • Folger Hill Asset Management sold 3,304 ResMed shares in Q2 2017, an estimated $238K.
  • Folger Hill Asset Management first reported a position in ResMed in Q1 2017 and held it in 1 quarter.
  • Folger Hill Asset Management's ResMed position peaked at $238K in Q1 2017.
  • 339 funds tracked by Wall St. Rank held ResMed as of Q2 2017.

Based on Folger Hill Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.